Clinical Trial Update: Cetuximab, Radiotherapy and Twice Weekly Gemcitabine to Treat Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating cetuximab with radiotherapy and twice-weekly gemcitabine for pancreatic cancer completed, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-04-18